Menu
Close
Sign up for NPL updates
Close
Sign up for NPL updates

Receive regular emails from NPL to get a glimpse of our activities and see how our experts are informing and influencing scientific debate

Andrew Robinson

Andrew Robinson

Head of Nuclear Medicine Metrology

Andrew Robinson is the Head of Nuclear Medicine Metrology and a Principal Research Scientist at NPL. Since joining NPL in 2016, Andrew has led NPL’s work in nuclear medicine, including the establishment of the nuclear medicine imaging laboratory and development of traceability for quantitative nuclear medicine imaging.

Andrew completed his PhD in experimental nuclear physics at The University of Edinburgh in 2005. From 2005–2007 he worked at Argonne National Laboratory (Illinois, USA) focusing on radioactive beam studies of transfermium nuclei. He has been responsible for developing detector and data acquisition systems used for nuclear structure studies at a number of international research facilities. Following post-doctoral work at The University of York he moved to The University of Manchester where from 2011 his research focused on the translation of techniques from nuclear physics research to dosimetry for molecular radiotherapy.

His main research interests are the development of metrological traceability for SPECT and PET activity quantification and molecular radiotherapy dosimetry. This includes the application of Monte Carlo and 3D printing techniques to nuclear medicine imaging activity quantification.  Other research interests include the production of new isotopes for medical applications, imaging optimisation for new theranostic isotopes combinations, and the development of scientific computing techniques and high throughput computing cluster design.

Andrew currently holds honorary research positions with The Christie NHS Foundation Trust and The University of Manchester. He was the coordinator for the EMPIR project MRTDosimetry (15HLT06) on metrology for clinical implementation of dosimetry in molecular radiotherapy (2016-2019) and is currently the coordinator for PINICAL-MRT (EMPIR 19SIP01) “Protocols for clinical impact in molecular radiotherapy”. He is a current member of the CIPM CCRI Radiopharmaceutical Therapy Working Group.

Areas of interest

  • Traceability for SPECT and PET activity quantification and calibration
  • Dosimetry for molecular radiotherapy
  • Monte Carlo simulation of nuclear medicine imaging
  • Phantom production using 3D printing

 

Email Andrew Robinson